KLF4 is a therapeutically tractable brake on fibroblast activation that promotes resolution of pulmonary fibrosis
Loka R. Penke(Pulmonary and Critical Care Associates), Marc Peters‐Golden(Pulmonary and Critical Care Associates)
Cited by 36
Related Papers
Hypermethylation of PTGER2 Confers Prostaglandin E2 Resistance in Fibrotic Fibroblasts from Humans and Mice
|American Journal Of Pathology|2010|141
Leukotriene B4 amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression
|Journal of Clinical Investigation|2011|139
FOXM1 is a critical driver of lung fibroblast activation and fibrogenesis
|Journal of Clinical Investigation|2018|128
Myofibroblast dedifferentiation proceeds via distinct transcriptomic and phenotypic transitions
|JCI Insight|2021|86
Specific Leukotriene Receptors Couple to Distinct G Proteins to Effect Stimulation of Alveolar Macrophage Host Defense Functions
|The Journal of Immunology|2007|75